Your browser doesn't support javascript.
loading
[Application value of real-time three-dimensional contrast-enhanced ultrasound for morphological assessing of hepatocellular carcinoma before radiofrequency ablation treatment].
Wang, X C; Li, S Y; Fang, Y; Zhou, L; Xu, L L; Wu, Y.
Afiliação
  • Wang XC; Department of Ultrasound, Hangzhou Xiasha Hospital, Xiasha Campus of Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou 310018, China.
  • Li SY; Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou 310016, China.
  • Fang Y; Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou 310016, China.
  • Zhou L; Department of Ultrasound, Hangzhou Xiasha Hospital, Xiasha Campus of Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou 310018, China.
  • Xu LL; Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou 310016, China.
  • Wu Y; Department of Ultrasound, Hangzhou Xiasha Hospital, Xiasha Campus of Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou 310018, China.
Zhonghua Zhong Liu Za Zhi ; 40(3): 217-221, 2018 Mar 23.
Article em Zh | MEDLINE | ID: mdl-29575843
ABSTRACT

Objective:

To investigate the evaluating ability of real-time three-dimensional contrast-enhanced ultrasound (RT-3D-CEUS) for morphology of hepatocellular carcinoma (HCC) before radiofrequency ablation (RFA) treatment.

Methods:

Sixty patients with 88 targeted lesions were enroll in this study, who have received RFA in Hangzhou Xiasha Hospital. The pretreatment imaging data of CEUS and RT-3D-CEUS were retrospective analysis. Morphological features were assessed according to the size and shape of the lesions, and were compared between two modalities with the post-treatment response as the reference standard.

Results:

The size of lesion measured by CEUS and RT-3D-CEUS was similar in 70 out of 88 lesions (group A). In the other 18 lesions, the size measured by RT-3D-CEUS was larger than that by CEUS (group B). For the shape analysis, 38 lesions were spheroid by CEUS and 34 lesions by RT-3D-CEUS; 47 lesions were oval by CEUS and 41 lesions by RT-3D-CEUS; 3 lesions were irregular by CEUS and 13 lesions by RT-3D-CEUS. There were 78 lesions which shape assessed by two modalities consistently (group A'), and the other 10 lesions with inconsistent shape by two modalities (group B'). Three months follow-up results showed that 4 lesions appeared tumor residue (5.7%) in group A' and 6 lesions (33.3%) in group B'. There was significant difference between these two groups (P=0.004). In the group A', there were 6 lesions (7.7%) showed tumor residue, and 4 lesions (40.0%) in group B'. The difference between these two groups was also significant (P=0.012).

Conclusion:

RT-3D-CEUS could be used to assess the size and shape of HCC accurately which is associated with the response of RFA.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ablação por Cateter / Carcinoma Hepatocelular / Meios de Contraste / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: Zh Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ablação por Cateter / Carcinoma Hepatocelular / Meios de Contraste / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: Zh Ano de publicação: 2018 Tipo de documento: Article